摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

cyclohexane-1,2-dione(phenyl)hydrazone | 2257-13-8

中文名称
——
中文别名
——
英文名称
cyclohexane-1,2-dione(phenyl)hydrazone
英文别名
cyclohexane-1,2-dione-mono-(4-nitro-phenylhydrazone);Cyclohexan-1,2-dion-mono-(4-nitro-phenylhydrazon);1-(4-Nitro-phenylhydrazono)-cyclohexanon-(2);cyclohexane-1,2-dione (4-nitrophenyl) hydrazone;Cyclohexane-1,2-dione (4-nitrophenyl)hydrazone;2-[(4-nitrophenyl)hydrazinylidene]cyclohexan-1-one
cyclohexane-1,2-dione(phenyl)hydrazone化学式
CAS
2257-13-8
化学式
C12H13N3O3
mdl
——
分子量
247.254
InChiKey
LTGSLBNCOXOGEC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    228-230 °C
  • 沸点:
    415.8±47.0 °C(Predicted)
  • 密度:
    1.36±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    87.3
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    参考文献:
    名称:
    CAN-SiO2介导的1-酮,1,2,3,4-四氢咔唑的一锅法氧化为咔唑醌:高效合成Murrayaquinone A和koeniginequinone A
    摘要:
    通过CAN-SiO 2介导的反应可以有效地将取代的1-酮-1,2,3,4-四氢咔唑(1)一锅法氧化为咔唑-1,4-醌(2)。该通用方案已成功扩展到两种天然存在的咔唑醌的合成:murrayaquinone A(2b)和koeniginequinone A(2g)。这种新反应的可能机制涉及形成9-羟基-2,3,4,9-四氢-1 H-咔唑-1-酮,然后重排为1-羟基咔唑衍生物,这些衍生物会被铈进一步氧化(IV )到咔唑醌。J.杂环化​​学。(2011)。
    DOI:
    10.1002/jhet.561
  • 作为产物:
    描述:
    2-环己酮甲酸乙酯 在 alkaline solution 作用下, 生成 cyclohexane-1,2-dione(phenyl)hydrazone
    参考文献:
    名称:
    166.重氮盐与环状β-酮酸衍生物的偶联
    摘要:
    DOI:
    10.1039/jr9370000807
点击查看最新优质反应信息

文献信息

  • [EN] TETRACYCLIC PYRAZOLE DERIVATIVES AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM<br/>[FR] DERIVES DE PYRAZOLE TETRACYCLIQUE UTILISES COMME INHIBITEURS DE KINASE, PROCESSUS DE PREPARATION CORRESPONDANT ET COMPOSITIONS PHARMACEUTIQUES LES COMPRENANT
    申请人:PHARMACIA ITALIA SPA
    公开号:WO2004071507A1
    公开(公告)日:2004-08-26
    The present invention provides a method for treating diseases caused by and/or associated with an altered protein kinase activity which comprises administering to a mammal in need thereof an effective amount of a tetracyclic pyrazole. The invention also provides specific tetracyclic pyrazole derivatives, useful intermediates, a library comprising at least two of them, a process for their preparation and the pharmaceutical compositions containing them, which are useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, viral infections, autoimmune diseases and neurodegenerative disorders.
    本发明提供了一种治疗由改变的蛋白激酶活性引起和/或与之相关的疾病的方法,包括向需要的哺乳动物施用有效量的四环吡唑。该发明还提供了特定的四环吡唑衍生物、有用的中间体、包含至少两种中间体的库、它们的制备方法以及含有它们的药物组合物,这些药物组合物在治疗由改变的蛋白激酶活性引起和/或与之相关的疾病方面具有用处,如癌症、细胞增殖障碍、病毒感染、自身免疫疾病和神经退行性疾病。
  • Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
    申请人:Vanotti Ermes
    公开号:US20060264493A1
    公开(公告)日:2006-11-23
    The present invention provides a method for treating diseases caused by and/or associated with an altered protein kinase activity which comprises administering to a mammal in need thereof an effective amount of a tetracyclic pyrazole. The invention also provides specific tetracyclic pyrazole derivatives, useful intermediates, a library comprising at least two of them, a process for their preparation and the pharmaceutical compositions containing them, which are useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, viral infections, autoimmune diseases and neurodegenerative disorders.
    本发明提供了一种治疗由改变的蛋白激酶活性引起和/或相关的疾病的方法,包括向需要治疗的哺乳动物中给予有效量的四环吡唑。本发明还提供了特定的四环吡唑衍生物、有用的中间体、包含至少两个四环吡唑衍生物的库、它们的制备方法以及含有它们的药物组合物,这些组合物对于治疗由改变的蛋白激酶活性引起和/或相关的疾病,如癌症、细胞增殖性疾病、病毒感染、自身免疫性疾病和神经退行性疾病非常有用。
  • Sen; Ghosh, Journal of the Indian Chemical Society, 1927, vol. 4, p. 484
    作者:Sen、Ghosh
    DOI:——
    日期:——
  • Substituted tetrahydrocarbazoles with potent activity against human papillomaviruses
    作者:Kristjan S. Gudmundsson、Paul R. Sebahar、Leah D’Aurora Richardson、John G. Catalano、Sharon D. Boggs、Andrew Spaltenstein、Phiroze B. Sethna、Kevin W. Brown、Robert Harvey、Karen R. Romines
    DOI:10.1016/j.bmcl.2009.05.003
    日期:2009.7
    The synthesis and SAR of a series of substituted 1-aminotetrahydrocarbazoles with potent activity against human papillomaviruses are described. Synthetic approaches allowing for variation of the substitution pattern of the tetrahydrocarbazole are outlined and resulting changes in antiviral activity are highlighted. Several compounds with in vitro antiviral activity (W12 antiviral assay) in the low nanomolar range were identified and (1R)-6-bromo-N-[(1R)-1-phenylethyl]-2,3,4,9-tetrahydro-1H-carbazole-1-amine was selected for further evaluation. (C) 2009 Elsevier Ltd. All rights reserved.
  • Chakraborty, Suchandra; Chattopadhyay, Gautam; Saha, Chandan, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2011, vol. 50, # 2, p. 201 - 206
    作者:Chakraborty, Suchandra、Chattopadhyay, Gautam、Saha, Chandan
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐